Clinical TopicsWeb Exclusives
fda treatment erdheim chester disease cancer blood

FDA approves first treatment for Erdheim-Chester Disease

Share

On Nov. 6, the U.S. Food and Drug Administration (FDA) expanded approval of Zelboraf (vemurafenib) to treat certain adult patients with Erdheim-Chester Disease. Read more via Fda.gov.

Poll

How often do you discuss nutrition's impact on mental health with patients?

Julie NyhusGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts